Abstract
Uterine leiomyoma (UL) is the most common benign neoplasm of the uterus. It is still unknown surely what exactly initiates transformation of the uterine myometrial cells into UL. To study the effect of the TP53gene variants on the risk of development and clinical features of UL. Case-control study was performed using molecular genetic analyses of variants rs1042522 (119G>C) and rs1625895 (13494G>A) of TP53gene in patients with UL and comparison group of healthy women. Investigated TP53gene variants were not associated with the risk of UL development. The patients with the 13494GG genotype (rs1625895) had significantly more often subserous UL (р< 0.05). In patients with heterozygous variant of TP53- 13494GA genotype (rs1625895) intramural UL was observed (р< 0.05). The rs1625895 (13494G>A) variant of TP53gene was associated with UL localization. The identified dependence of the UL localization on the TP53gene variant could be useful for personalized approach to treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
